The Food and Drug Administration is looking for public input on the agency’s efforts to modernize its data strategy, including approaches to quality, stewardship, exchange and analytics.
The FDA announced that it will conduct a public meeting on March 27 at the White Oak campus in Silver Spring, Md. According to the announcement, the agency intends to develop a modernized enterprise-wide strategic approach not only to technology—but to data itself.
